Viewing Study NCT05985694


Ignite Creation Date: 2025-12-25 @ 1:44 AM
Ignite Modification Date: 2025-12-26 @ 12:54 AM
Study NCT ID: NCT05985694
Status: COMPLETED
Last Update Posted: 2025-09-10
First Post: 2023-07-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: AD17002 Treating Poorly Controlled, Moderate to Severe Eosinophilic Asthma
Sponsor: Advagene Biopharma Co. Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module